We’ve talked about BPA before.
In recent years, the Food and Drug Administration (FDA) has preferred a relatively nonchalant approach to the carcinogenic chemical that’s present in food containers and drink bottles across the country, declining to upgrade the risk in line with scientists’ concerns.
Experts in the field have long felt the FDA’s position has jarred with the more cautionary scientific view.
“The stance the FDA’s had for a number of years is probably narrow-sighted.” – Christopher Kassotis, University of Missouri
That cautious concern appears to have been vindicated by a significant report in The Lancet that the methodology used by regulators to quantify BPA is …